Altered plasma protein glycosylation in a mouse model of depression and in patients with major depression

Journal of Affective Disorders

Volumn 233, Issue , 2018, Pages 79-85

  Yamagata, Hirotaka ^a   Uchida, Shusaku ^a   Matsuo, Koji ^a   Harada, Kenichiro ^a   Kobayashi, Ayumi ^a   Nakashima, Mami ^a,b   Higuchi, Fumihiro ^a   Watanuki, Toshio ^a   Matsubara, Toshio ^a,c   Watanabe, Yoshifumi ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nagatoichinomiya Hospital   (Japan)

^c YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Biomarkers; Depression; Gene expression; Glycosylation

Indexed keywords

ALPHA N ACETYLGALACTOSAMINIDE ALPHA 2,6 SIALYLTRANSFERASE; BETA GALACTOSIDE ALPHA 2,6 SIALYLTRANSFERASE; COMPLEMENTARY DNA; GLYCAN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMIPRAMINE; LECTIN; PLASMA PROTEIN; SIALYLTRANSFERASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GALACTOSYL-1-3-N-ACETYLGALACTOSAMINYL-SPECIFIC 2,6-SIALYLTRANSFERASE; ST6GALNAC2 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR DEPRESSION; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN GLYCOSYLATION; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; RNA ISOLATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; DEPRESSION; DISEASE MODEL; GENE EXPRESSION; GENETIC MARKER; GENETICS; GLYCOSYLATION; PHYSIOLOGY;

ANIMALS; BIOMARKERS; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENETIC MARKERS; GLYCOSYLATION; HUMANS; LECTINS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SIALYLTRANSFERASES;

EID: 85028346236     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2017.08.057     Document Type: Article

References (44)

1. Abe, N., Uchida, S., Otsuki, K., Hobara, T., Yamagata, H., Higuchi, F., Shibata, T., Watanabe, Y., Altered sirtuin deacetylase gene expression in patients with a mood disorder. J. Psychiatr. Res. 45 (2011), 1106–1112.
2. Abe-Higuchi, N., Uchida, S., Yamagata, H., Higuchi, F., Hobara, T., Hara, K., Kobayashi, A., Watanabe, Y., Hippocampal sirtuin 1 signaling mediates depression-like behavior. Biol. Psychiatry, 2016.
3. Adamczyk, B., Tharmalingam, T., Rudd, P.M., Glycans as cancer biomarkers. Biochim. Biophys. Acta (BBA) - Gen. Subj. 1820 (2012), 1347–1353.
4. Almeida, A., Kolarich, D., The promise of protein glycosylation for personalised medicine. Biochim. Biophys. Acta (BBA) - Gen. Subj. 1860 (2016), 1583–1595.
5. American_Psychiatric_Association, Diagnostic and Statistical Manual of Mental Disordersn, Text Revision (DSM-IV-TR). fourth ed., 2000.
6. Barbeau, D., Liang, J.J., Robitalille, Y., Quirion, R., Srivastava, L.K., Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc. Natl. Acad. Sci. USA 92 (1995), 2785–2789.
7. Baskakov, I.V., Katorcha, E., Multifaceted role of sialylation in prion diseases. Front. Neurosci., 10, 2016.
8. Catera, M., Borelli, V., Malagolini, N., Chiricolo, M., Venturi, G., Reis, C.A., Osorio, H., Abruzzo, P.M., Capri, M., Monti, D., Ostan, R., Franceschi, C., Dall'Olio, F., Identification of novel plasma glycosylation-associated markers of aging. Oncotarget 7 (2016), 7455–7468.
9. Cha, S.K., Ortega, B., Kurosu, H., Rosenblatt, K.P., Kuro-o, M., Huang, C.L., Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc. Natl. Acad. Sci. USA 105 (2008), 9805–9810.
10. Dall'Olio, F., Vanhooren, V., Chen, C.C., Slagboom, P.E., Wuhrer, M., Franceschi, C., N-glycomic biomarkers of biological aging and longevity: a link with inflammaging. Ageing Res. Rev. 12 (2013), 685–698.
11. Dalziel, M., Crispin, M., Scanlan, C.N., Zitzmann, N., Dwek, R.A., Emerging principles for the therapeutic exploitation of glycosylation. Science, 343, 2014 (1235681-1235681).
12. Folstein, M.F., Folstein, S.E., McHugh, P.R., “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975), 189–198.
13. Ghio, L., Gotelli, S., Marcenaro, M., Amore, M., Natta, W., Duration of untreated illness and outcomes in unipolar depression: a systematic review and meta-analysis. J. Affect. Disord. 152–154 (2014), 45–51.
14. Hamilton, M., A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960), 56–62.
15. Harada, K., Matsuo, K., Nakashima, M., Hobara, T., Higuchi, N., Higuchi, F., Nakano, M., Otsuki, K., Shibata, T., Watanuki, T., Matsubara, T., Fujita, Y., Shimoji, K., Yamagata, H., Watanabe, Y., Disrupted orbitomedial prefrontal limbic network in individuals with later-life depression. J. Affect. Disord. 204 (2016), 112–119.
16. Higuchi, F., Uchida, S., Yamagata, H., Otsuki, K., Hobara, T., Abe, N., Shibata, T., Watanabe, Y., State-dependent changes in the expression of DNA methyltransferases in mood disorder patients. J. Psychiatr. Res. 45 (2011), 1295–1300.
17. Higuchi, F., Uchida, S., Yamagata, H., Abe-Higuchi, N., Hobara, T., Hara, K., Kobayashi, A., Shintaku, T., Itoh, Y., Suzuki, T., Watanabe, Y., Hippocampal MicroRNA-124 enhances chronic stress resilience in mice. J. Neurosci. 36 (2016), 7253–7267.
18. Hirabayashi, J., Kuno, A., Tateno, H., Lectin-based structural glycomics: a practical approach to complex glycans. Electrophoresis 32 (2011), 1118–1128.
19. Hirabayashi, J., Yamada, M., Kuno, A., Tateno, H., Lectin microarrays: concept, principle and applications. Chem. Soc. Rev., 42, 2013, 4443.
20. Hobara, T., Uchida, S., Otsuki, K., Matsubara, T., Funato, H., Matsuo, K., Suetsugi, M., Watanabe, Y., Altered gene expression of histone deacetylases in mood disorder patients. J. Psychiatr. Res. 44 (2010), 263–270.
21. Isomura, R., Kitajima, K., Sato, C., Structural and functional impairments of polysialic acid by a mutated polysialyltransferase found in schizophrenia. J. Biol. Chem. 286 (2011), 21535–21545.
22. Jacobs, J.M., Miura, Y., Hashii, N., Tsumoto, H., Takakura, D., Ohta, Y., Abe, Y., Arai, Y., Kawasaki, N., Hirose, N., Endo, T., Change in N-glycosylation of plasma proteins in Japanese semisupercentenarians. PLoS One, 10, 2015, e0142645.
23. Kanda, Y., Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 48 (2012), 452–458.
24. Liang, H.-C., Russell, C., Mitra, V., Chung, R., Hye, A., Bazenet, C., Lovestone, S., Pike, I., Ward, M., Glycosylation of human plasma clusterin yields a novel candidate biomarker of alzheimer's disease. J. Proteome Res. 14 (2015), 5063–5076.
25. Maguire, T.M., Thakore, J., Dinan, T.G., Hopwood, S., Breen, K.C., Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis function. Biol. Psychiatry 41 (1997), 1131–1136.
26. Miyata, S., Kurachi, M., Okano, Y., Sakurai, N., Kobayashi, A., Harada, K., Yamagata, H., Matsuo, K., Takahashi, K., Narita, K., Fukuda, M., Ishizaki, Y., Mikuni, M., Blood transcriptomic markers in patients with late-onset major depressive disorder. PLoS One, 11, 2016, e0150262.
27. Mueller, T.M., Haroutunian, V., Meador-Woodruff, J.H., N-glycosylation of GABAA receptor subunits is altered in schizophrenia. Neuropsychopharmacology 39 (2013), 528–537.
28. Nagamine, S., Yamazaki, T., Makioka, K., Fujita, Y., Ikeda, M., Takatama, M., Okamoto, K., Yokoo, H., Ikeda, Y., Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains. Neuropathology 36 (2016), 333–345.
29. Ohtsubo, K., Marth, J.D., Glycosylation in cellular mechanisms of health and disease. Cell 126 (2006), 855–867.
30. Otsubo, T., Tanaka, K., Koda, R., Shinoda, J., Sano, N., Tanaka, S., Aoyama, H., Mimura, M., Kamijima, K., Reliability and validity of Japanese version of the mini-international neuropsychiatric interview. Psychiatry Clin. Neurosci. 59 (2005), 517–526.
31. Otsuki, K., Uchida, S., Watanuki, T., Wakabayashi, Y., Fujimoto, M., Matsubara, T., Funato, H., Watanabe, Y., Altered expression of neurotrophic factors in patients with major depression. J. Psychiatr. Res. 42 (2008), 1145–1153.
32. Paroni, G., Seripa, D., Fontana, A., D'Onofrio, G., Gravina, C., Urbano, M., Addante, F., Lozupone, M., Copetti, M., Pilotto, A., Greco, A., Panza, F., Klotho gene and selective serotonin reuptake inhibitors: response to treatment in late-life major depressive disorder. Mol. Neurobiol., 2016.
33. Pavlatou, M.G., Remaley, A.T., Gold, P.W., Klotho: a humeral mediator in CSF and plasma that influences longevity and susceptibility to multiple complex disorders, including depression. Transl. Psychiatry, 6, 2016, e876.
34. Ping, P., Vondriska, T.M., Creighton, C.J., Gandhi, T.K., Yang, Z., Menon, R., Kwon, M.S., Cho, S.Y., Drwal, G., Kellmann, M., Peri, S., Suresh, S., Gronborg, M., Molina, H., Chaerkady, R., Rekha, B., Shet, A.S., Gerszten, R.E., Wu, H., Raftery, M., Wasinger, V., Schulz-Knappe, P., Hanash, S.M., Paik, Y.K., Hancock, W.S., States, D.J., Omenn, G.S., Pandey, A., A functional annotation of subproteomes in human plasma. Proteomics 5 (2005), 3506–3519.
35. Pivac, N., Knezevic, A., Gornik, O., Pucic, M., Igl, W., Peeters, H., Crepel, A., Steyaert, J., Novokmet, M., Redzic, I., Nikolac, M., Hercigonja, V.N., Curkovic, K.D., Curkovic, M., Nedic, G., Muck-Seler, D., Borovecki, F., Rudan, I., Lauc, G., Human plasma glycome in attention-deficit hyperactivity disorder and autism spectrum disorders. Mol. Cell Proteom., 10, 2011 (M110 004200).
36. Ruhaak, L.R., Uh, H.-W., Beekman, M., Hokke, C.H., Westendorp, R.G.J., Houwing-Duistermaat, J., Wuhrer, M., Deelder, A.M., Slagboom, P.E., Plasma protein N-glycan profiles are associated with calendar age, familial longevity and health. J. Proteome Res. 10 (2011), 1667–1674.
37. Schedin-Weiss, S., Winblad, B., Tjernberg, L.O., The role of protein glycosylation in Alzheimer disease. FEBS J. 281 (2014), 46–62.
38. Shibata, T., Yamagata, H., Uchida, S., Otsuki, K., Hobara, T., Higuchi, F., Abe, N., Watanabe, Y., The alteration of hypoxia inducible factor-1 (HIF-1) and its target genes in mood disorder patients. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 43 (2013), 222–229.
39. Stowell, S.R., Ju, T., Cummings, R.D., Protein glycosylation in cancer. Annu. Rev. Pathol. 10 (2015), 473–510.
40. Uchida, S., Hara, K., Kobayashi, A., Otsuki, K., Yamagata, H., Hobara, T., Suzuki, T., Miyata, N., Watanabe, Y., Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 69 (2011), 359–372.
41. Wielgat, P., Walesiuk, A., Braszko, J.J., Effects of chronic stress and corticosterone on sialidase activity in the rat hippocampus. Behav. Brain Res. 222 (2011), 363–367.
42. Willison, H.J., Goodyear, C.S., Glycolipid antigens and autoantibodies in autoimmune neuropathies. Trends Immunol. 34 (2013), 453–459.
43. World_Health_Organization, World_Health_Organization, 2004. The Global Burden of Disease: 2004 Update. 2004.
44. Yoo, S.W., Motari, M.G., Susuki, K., Prendergast, J., Mountney, A., Hurtado, A., Schnaar, R.L., Sialylation regulates brain structure and function. FASEB J. 29 (2015), 3040–3053.